ISSN 1671-5411 CN 11-5329/R
Volume 18 Issue 8
Aug.  2021
Turn off MathJax
Article Contents
Please cite this article as: XIANG W, KONG LY, BAI J, XIE JJ, LIU F. Short-term observation of direct oral anticoagulant use in an atrial fibrillation patient with high bleeding risk and kidney transplant: a case report. J Geriatr Cardiol 2021; 18(8): 692−696. DOI: 10.11909/j.issn.1671-5411.2021.08.010
Citation: Please cite this article as: XIANG W, KONG LY, BAI J, XIE JJ, LIU F. Short-term observation of direct oral anticoagulant use in an atrial fibrillation patient with high bleeding risk and kidney transplant: a case report. J Geriatr Cardiol 2021; 18(8): 692−696. DOI: 10.11909/j.issn.1671-5411.2021.08.010

Short-term observation of direct oral anticoagulant use in an atrial fibrillation patient with high bleeding risk and kidney transplant: a case report

doi: 10.11909/j.issn.1671-5411.2021.08.010
More Information
  • loading
  • [1]
    Tonelli M, Wiebe N, Knoll G, et al. Systematic review: kidney transplantation compared with dialysis in clinically relevant outcomes. Am J Transplant 2011; 11: 2093−2109. doi: 10.1111/j.1600-6143.2011.03686.x
    [2]
    Purnell TS, Auguste P, Crews DC, et al. Comparison of life participation activities among adults treated by hemodialysis, peritoneal dialysis, and kidney transplantation: a systematic review. Am J Kidney Dis 2013; 62: 953−973. doi: 10.1053/j.ajkd.2013.03.022
    [3]
    Thongprayoon C, Chokesuwattanaskul R, Bathini T, et al. Epidemiology and prognostic importance of atrial fibrillation in kidney transplant recipients: a meta-analysis. J Clin Med 2018; 7: 370. doi: 10.3390/jcm7100370
    [4]
    January CT, Wann LS, Calkins H, et al. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines and the Heart Rhythm Society in collaboration with the Society of Thoracic Surgeons. Circulation 2019; 140: e125−e151. doi: 10.1161/CIR.0000000000000665
    [5]
    Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace 2016; 18: 1609−1678. doi: 10.1093/europace/euw295
    [6]
    Chan N, Sobieraj-Teague M, Eikelboom JW. Direct oral anticoagulants: evidence and unresolved issues. Lancet 2020; 396: 1767−1776. doi: 10.1016/S0140-6736(20)32439-9
    [7]
    Malyszko J, Lopatowska P, Mlodawska E, et al. Atrial fibrillation in kidney transplant recipients: is there a place for the novel drugs? Nephrol Dial Transplant 2018; 33: 1304−1309. doi: 10.1093/ndt/gfx265
    [8]
    Eriksson BI, Quinlan DJ, Weitz JI. Comparative pharmacodynamics and pharmacokinetics of oral direct thrombin and factor Xa inhibitors in development. Clin Pharmacokinet 2009; 48: 1−22. doi: 10.2165/0003088-200948010-00001
    [9]
    Lemahieu WP, Maes BD, Verbeke K, et al. CYP3A4 and P-glycoprotein activity in healthy controls and transplant patients on cyclosporin vs. tacrolimus vs. sirolimus. Am J Transplant 2004; 4: 1514−1522. doi: 10.1111/j.1600-6143.2004.00539.x
    [10]
    Amundsen R, Åsberg A, Ohm IK, et al. Cyclosporine A- and tacrolimus-mediated inhibition of CYP3A4 and CYP3A5 in vitro. Drug Metab Dispos 2012; 40: 655−661. doi: 10.1124/dmd.111.043018
    [11]
    Steffel J, Verhamme P, Potpara TS, et al. The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Eur Heart J 2018; 39: 1330−1393. doi: 10.1093/eurheartj/ehy136
    [12]
    Camporese G, Bernardi D, Bernardi E, et al. Absence of interaction between rivaroxaban, tacrolimus and everolimus in renal transplant recipients with deep vein thrombosis or atrial fibrillation. Vascul Pharmacol 2020; 130: 106682. doi: 10.1016/j.vph.2020.106682
    [13]
    Basic-Jukic N, Furic-Cunko V, Juric I. Novel oral anticoagulants in renal transplant recipients: a retrospective cohort study. Pril (Makedon Akad Nauk Umet Odd Med Nauki) 2020; 41: 49−55. doi: 10.2478/prilozi-2020-0032
    [14]
    Leon J, Sabbah L, Aubert O, et al. Efficacy and safety of direct oral anticoagulants in kidney transplantation: a single-center pilot experience. Transplantation 2020; 104: 2625−2631. doi: 10.1097/TP.0000000000003168
    [15]
    Bukhari MA, Al-Theaby A, Tawhari M, et al. Efficacy and safety of non-vitamin K antagonist oral anticoagulants post-kidney transplantation. World J Transplant 2019; 9: 134−144. doi: 10.5500/wjt.v9.i6.134
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(6)

    Article Metrics

    Article views (52) PDF downloads(2) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return